SHUTTLEWORTH, Stephen Joseph,WHALE, Andrew David,COLMAN, Lucy Mary,ROGERS, Helen Louise
申请号：
SG11201810516U
公开号：
SG11201810516UA
申请日:
2017.06.05
申请国别(地区):
SG
年份:
2018
代理人:
摘要：
The invention relates to a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof, and at least one second agent selected from the group consisting of proteasome inhibitors, tumour immunotherapeutics or immunomodulatory agents, signal transduction pathway inhibitors, agents inhibiting the BCL2 family of proteins, agents inhibiting Mcl-1, poly (ADP-ribose) polymerase (PARP) Inhibitors, aromatase inhibitors, conventional cytotoxic agents or a miscellaneous agent selected from abiraterone, ARN-509 and MYC inhibitors.
